- Home
- INGN vs PRQR Comparison
INGN vs PRQR Comparison
Compare INGN & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- PRQR
- Stock Information
- Founded
- INGN 2001
- PRQR 2012
- Country
- INGN United States
- PRQR Netherlands
- Employees
- INGN N/A
- PRQR N/A
- Industry
- INGN Industrial Specialties
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- INGN Health Care
- PRQR Health Care
- Exchange
- INGN Nasdaq
- PRQR Nasdaq
- Market Cap
- INGN 219.3M
- PRQR 224.4M
- IPO Year
- INGN 2014
- PRQR 2014
- Fundamental
- Price
- INGN $8.69
- PRQR $2.36
- Analyst Decision
- INGN Strong Buy
- PRQR Strong Buy
- Analyst Count
- INGN 3
- PRQR 8
- Target Price
- INGN $11.00
- PRQR $8.88
- AVG Volume (30 Days)
- INGN 185.5K
- PRQR 403.1K
- Earning Date
- INGN 11-06-2025
- PRQR 11-06-2025
- Dividend Yield
- INGN N/A
- PRQR N/A
- EPS Growth
- INGN N/A
- PRQR N/A
- EPS
- INGN N/A
- PRQR N/A
- Revenue
- INGN $343,472,000.00
- PRQR $20,129,184.00
- Revenue This Year
- INGN $7.93
- PRQR N/A
- Revenue Next Year
- INGN $8.18
- PRQR N/A
- P/E Ratio
- INGN N/A
- PRQR N/A
- Revenue Growth
- INGN 5.15
- PRQR 8.65
- 52 Week Low
- INGN $5.70
- PRQR $1.07
- 52 Week High
- INGN $12.91
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- INGN 58.20
- PRQR 57.39
- Support Level
- INGN $8.24
- PRQR $2.25
- Resistance Level
- INGN $8.84
- PRQR $2.54
- Average True Range (ATR)
- INGN 0.32
- PRQR 0.13
- MACD
- INGN -0.03
- PRQR 0.02
- Stochastic Oscillator
- INGN 61.49
- PRQR 70.31
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.